Improving vitamin A coverage through co-implementation with seasonal malaria chemoprevention
Published:
Resources: Project brief
This study aims to generate evidence to support decision-making on integrating vitamin A supplementation into SMC in Nigeria.
Vitamin A deficiency is a major risk factor for child survival. Seasonal malaria chemoprevention (SMC) — the door-to-door delivery of antimalarials to children 3–59 months over four to five monthly cycles during the peak malaria season — offers an existing, viable platform within which vitamin A supplementation (VAS) can be fully integrated to achieve higher coverage of at least one dose of vitamin A. This study is taking place in northeast Nigeria, it delivers SMC to children 3–59 months and VAS to children 6–59 months during the last SMC cycle.
